{"entity":{"id":"nct06658353","kind":"trial","name":"Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors","aka":[],"tldr":"A phase 3 trial testing VC004, now recruiting.","summary":"Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours is a phase 3 interventional study registered as NCT06658353, led by Jiangsu vcare pharmaceutical technology co., and recruiting on the registry. Official title: Single-arm, Open, Multi-centre Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours. Planned enrolment is 54 participants (estimated). The study started in 2025-03-17 and primary completion is expected in 2026-12-30. No results have been posted on ClinicalTrials.gov.","status":"recruiting","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov NCT06658353","url":"https://clinicaltrials.gov/study/NCT06658353"}],"tags":["ctgov-ingest"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["vc004"],"companies":[],"institutions":[],"pathways":[],"terms":["single-arm","metastasis"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06658353","phase":"3","setting":"Single-arm, Open, Multi-center Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors","sponsor":"Jiangsu vcare pharmaceutical technology co.","started":"2025-03-17","startedType":"actual","enrolled":54,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06658353/","neighbours":{"drug":[{"id":"vc004","kind":"drug","name":"VC004","route":"/drugs/vc004/"}],"term":[{"id":"metastasis","kind":"term","name":"Metastasis","route":"/terms/metastasis/"},{"id":"single-arm","kind":"term","name":"Single-arm trial","route":"/terms/single-arm/"}]}}